Negative Pressure Wound Therapy (NPWT) Market By Product (Conventional/Traditional, Single-use, Accessories), Wound Type (Diabetic Foot Ulcer [DFU], Venous Leg Ulcer, Surgical, Burn, Skin Grafts), End User (Hospital, Home Care) - Global Forecast to 2030

The Negative Pressure Wound Therapy Market is projected to reach $4.04 billion by 2030, at a CAGR of 6% from 2024 to 2030. Negative pressure wound therapy (NPWT), also called vacuum-assisted wound closure, aims to optimize the physiological process of wound healing. It promotes the process of wound healing in acute or chronic wounds. NPWT uses negative pressure or suction to facilitate wound healing. The vacuum is applied to the wound through a specialized dressing or wound vacuum system. Negative pressure wound therapy is used in various types of wounds, such as diabetic foot ulcers, venous or arterial ulcers, surgical wounds, pressure ulcers, and burn wounds. It facilitates the process of wound healing through several pathways, including removal of excess fluid, promotion of blood flow, stimulation of tissue formation, reduction of edema, and wound contraction.

The growth of this market is driven by the increasing prevalence of diabetes and chronic wounds, rising elderly population, favorable reimbursement policies and increasing incidence of obesity and associated comorbidities. In addition, the technological advancements in negative pressure wound therapy devices and emerging economies are expected to provide significant growth opportunities for this market.

However, the high costs of NPWT devices and the potential risk of complications are expected to restrain the growth of this market to a certain extent. In addition, factors such as the limited awareness and training of healthcare professionals and the lack of adherence to the treatment among patients due to discomfort pose major challenges to the market’s growth.

The Increasing Prevalence of Diabetes and Chronic Wounds is Driving the Negative Pressure Wound Therapy Market

Diabetes is a chronic disease that can lead to several health complications. One of the major health complications it causes is impairment of wound healing. Individuals with diabetes are more prone to developing chronic wounds, such as diabetic foot ulcers. These wounds often occur due to neuropathy and peripheral arterial disease associated with diabetes. The prevalence of diabetes has been steadily increasing globally, primarily due to factors such as sedentary lifestyles, unhealthy dietary habits, and rising elderly population. According to the International Diabetes Federation (IDF), the number of people living with diabetes is estimated to increase from 537 million in 2021 to 643 million by 2030 and 783 million by 2045.

Chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, are a common complication in people with diabetes. Due to diabetic conditions, these wounds often exhibit impaired healing, causing an increased risk of infections and higher amputation rates if not managed properly.

Negative pressure wound therapy has been proven to effectively treat chronic wounds such as diabetic foot ulcers. It promotes wound healing by removing excess fluid, reducing edema, enhancing blood circulation, and stimulating tissue formation. Thus, the rising prevalence of diabetes and chronic wounds drives the growth of the negative pressure wound therapy market.

Click here to: Get a Free Sample Copy of this report

High Costs of NPWT Systems to Hinder the Growth of this Market

The high costs of negative pressure wound therapy systems hinder the widespread adoption and utilization of this market. In addition, the expenses of dressings and disposable supplies can be a significant financial burden for healthcare facilities and patients.

The purchase of NPWT systems requires substantial initial capital investment by healthcare facilities or providers. Additionally, disposable supplies such as foam or gauze dressings, adhesive films, canisters, and tubing are required for this therapy. The costs of these supplies can accumulate over time and add to the overall cost of NPWT. These factors hinder the widespread adoption of negative pressure wound therapy, thereby hindering the growth of this market.

Key Findings of the Negative Pressure Wound Therapy Market Study:

In 2024, the Conventional/ Traditional NPWT Devices Segment is Expected to Dominate the Negative Pressure Wound Therapy Market

Based on product, the negative pressure wound therapy market is segmented into conventional/ traditional NPWT devices, single-use NPWT devices, and accessories & consumables. In 2024, the conventional/ traditional NPWT devices segment is expected to account for the largest share of the negative pressure wound therapy market. Conventional NPWT devices typically consist of a vacuum pump, tubing, and dressing materials, which create negative pressure or suction at the wound site to facilitate healing. Factors such as the widespread use of these devices in hospitals for various wounds, proven clinical outcomes, and the high preference for conventional NPWT devices among healthcare professionals contribute to the large market share of this segment.

In 2024, the Diabetic Foot Ulcers Segment is Expected to Dominate the Negative Pressure Wound Therapy Market

Based on wound type, the negative pressure wound therapy market is segmented into diabetic foot ulcers, venous leg ulcers, surgical wounds, skin grafts, burn wounds, and other wound types. In 2024, the diabetic foot ulcers segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to factors such as the high prevalence of diabetes, increased patient awareness, and clinical evidence showcasing improved patient outcomes with negative pressure wound therapy.

In 2024, the Hospitals & Clinics Segment is Expected to Dominate the Negative Pressure Wound Therapy Market

Based on end user, the negative pressure wound therapy market is segmented into hospitals & clinics, home care settings, and other end users. In 2024, the hospitals & clinics segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the increasing number of patients visiting hospitals & clinics for inpatient wound care, advanced infrastructure in hospitals for wound care treatments, and the availability of skilled healthcare professionals in hospitals & clinics.

Asia-Pacific: The Fastest-growing Regional Market

Asia-Pacific is slated to record the highest CAGR in the negative pressure wound therapy market during the forecast period. The growth of this regional market is driven by the increasing patient population, the rising prevalence of chronic diseases like diabetes, the ongoing development of healthcare infrastructure in the region, and favorable government initiatives aimed at enhancing wound care and promoting advanced medical technologies.

Key Players

The report includes a competitive landscape based on an extensive assessment of the market based on product, wound type, end user, and geography. The report also provides insights into the geographic presence of major market players and the key growth strategies adopted by them in the last three to four years.

The key players profiled in the negative pressure wound therapy market are Acelity L.P. Inc. (U.S.), Cardinal Health, Inc. (U.S.), Convatec Group plc (U.S.), DeRoyal Industries, Inc. (U.S.), Genadyne Biotechnologies, Inc. (U.S.), Medela AG (Switzerland), Mölnlycke Health Care AB (Sweden), Smith & Nephew plc (U.K.), PAUL HARTMANN AG (Germany), and Talley Group Ltd (U.K.).

Scope of the Report:

Negative Pressure Wound Therapy Market Assessment, by Product

• Conventional/Traditional NPWT Devices
• Single-use NPWT Devices
• Accessories & Consumables

Negative Pressure Wound Therapy Market Assessment, by Wound Type

• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Surgical Wounds
• Skin Grafts
• Burn Wounds
• Other Wound Types
  (Other wound types include Pressure Ulcers, wounds from infections, and traumatic wounds)

Negative Pressure Wound Therapy Market Assessment, by End User

• Hospitals & Clinics
• Home Care Settings
• Other End Users
  (Other end users primarily include long-term care facilities, ambulatory surgical centers, and rehabilitation centers)

Negative Pressure Wound Therapy Market Assessment, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Latin America
• Middle East & Africa

Key questions answered in the report: